Abiomed, Inc.ABMDNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank79
3Y CAGR+31.8%
5Y CAGR+1.2%
Year-over-Year Change
Price-to-earnings ratio
3Y CAGR
+31.8%/yr
vs +17.1%/yr prior
5Y CAGR
+1.2%/yr
Recent acceleration
Acceleration
+14.7pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2022 | 110.28 | +72.9% |
| 2021 | 63.80 | +97.5% |
| 2020 | 32.30 | -32.9% |
| 2019 | 48.16 | -58.0% |
| 2018 | 114.54 | +10.3% |
| 2017 | 103.87 | -1.0% |
| 2016 | 104.89 | +310.0% |
| 2015 | 25.58 | -81.6% |
| 2014 | 139.34 | +192.3% |
| 2013 | 47.67 | - |